Institutional Ownership Avadel Pharmaceuticals PLC (AVDL)
This table provides information about the institutional ownership of Avadel Pharmaceuticals PLC (AVDL). We have compiled data on the 8 institutions that hold shares in the stock, with a total of 1.07 Million shares, which have been reported (via 13F filing form) to have a value of $10.8 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Knoll Capital Management, LLC
Miami, FL |
Nov 14, 2024 Q3 2024 |
600,000
shares
|
$6.19 Million
3.88% of portfolio
|
Q3 2023
Added 20.0%
|
|
|
Knott David M Jr
Syosset, NY |
Nov 13, 2024 Q3 2024 |
332,000
shares
|
$3.42 Million
1.53% of portfolio
|
Q3 2024
Reduced 0.3%
|
|
|
Schulhoff & CO Inc
|
Nov 06, 2024 Q3 2024 |
137,000
shares
|
$1.41 Million
0.81% of portfolio
|
Q1 2024
Added 42.71%
|
|
|
1620 Investment Advisors, Inc.
Plymouth, MA |
Oct 25, 2024 Q3 2024 |
1,000
shares
|
$10,310
0.01% of portfolio
|
Q2 2024
New holding
|
|
|
American Portfolios Advisors
Holbrook, NY |
Mar 17, 2023 Q3 2022 |
500
shares
|
$5,155
0.0% of portfolio
|
Q3 2022
New holding
|
|
|
American Research & Management Co.
|
Oct 07, 2022 Q3 2022 |
100
shares
|
$1,031
0.0% of portfolio
|
Q3 2020
New holding
|
|
|
Exane Derivatives
|
Jul 12, 2022 Q2 2022 |
33
shares
|
$340
0.0% of portfolio
|
Q1 2022
Reduced 86.25%
|
|
|
Huntington National Bank
Columbus, OH |
Nov 06, 2024 Q3 2024 |
1
shares
|
$10
0.0% of portfolio
|
Q4 2021
New holding
|